MKV
Dược thú Y Cai Lậy ·HNX ·2026Q1
▲▲ Improving positively
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, MKV is improving on both revenue and margins, suggesting current growth is backed by both scale and operating efficiency — profit is at an all-time high. The next test will be whether this pace holds as the comparison base gets tougher.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36.0 | 39.5 | 42.2 | 33.8 | 33.4 | 27.7 | 30.8 | 27.4 | 24.1 | 29.3 | 31.4 | 24.8 |
| Growth | -9% | -6% | +25% | +1% | +21% | -10% | +12% | +13% | -17% | -7% | +27% | — |
| Net Income | 1.0 | 7.0 | 5.7 | 2.3 | 2.0 | 0.3 | 1.8 | 3.5 | 1.8 | 1.8 | 2.0 | 1.3 |
| Net Margin | 2.91% | 17.70% | 13.50% | 6.71% | 5.86% | 0.92% | 6.00% | 12.80% | 7.36% | 6.14% | 6.47% | 5.20% |
Drivers of MKV's profit
Net profit attributable to parent increased vs last year, mainly helped by higher gross profit. Supporting and offsetting drivers:
Net profit attributable to parent declined vs prior quarter, mainly due to higher selling expenses. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE rose from 8.9% to 16.5% — mainly driven by asset turnover, despite leverage moving in the opposite direction.
Is the profit sustainable?
Margins are improving and earnings quality is solid — a durable foundation for ROE.
What is driving the margin?
Net margin expanded to 10.56%, rising 4.2pp. The main driver is SG&A / Revenue fell 4.3pp and Gross margin rose 0.4pp, moving in line with the stronger net margin (with additional support from Net financial result / Revenue rose 0.3pp).
The improvement comes from core operations — this is a high-quality margin expansion.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.
Is capital being deployed efficiently?
Track how much operating profit the business generates on invested capital.
Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC above should be read with industry context — the balance sheet below adds perspective. Balance sheet is exceptionally sound — liabilities at 0.12x equity, with a net cash position equivalent to 0.01x equity.
Inventory ended the period at 18.2bn, roughly 15.7% of total assets.
Over the last 12 months, working capital released 7.2bn of cash, mainly thanks to lower receivables. Pressure from higher inventories and lower payables only partly offset that benefit.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 32.9 days versus the same period last year. The main moves came from DIO rose 1.7 days, DSO fell 46.7 days, and DPO fell 12.1 days.
Improvement comes mainly from faster receivables collection — reflects the quality of receivables management.
Watchpoints
CCC stands at 127.2 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DIO increased by +1.7 days, suggesting more capital is being tied up in inventories.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — the company has net cash and CFO reached 21.3bn.
Leverage & Liquidity
Leverage looks fairly comfortable, with net debt / equity at -0.01x and interest coverage at 4.82x.
Debt maturity and the cash buffer remain the two key areas to monitor.
Some leverage signals are missing, so the current read should be treated as contextual.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 21.3bn in 2025, against investing cash flow of -22.0bn.
Post-investment cash flow was negative +0.8bn. Financing cash flow was positive 0.0bn.
CFO / net income was 1.63x.
Track how much investment can be funded internally from operating cash flow.
Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is entering a broader improvement phase — not just stronger earnings but better operating quality as well. Margin, ROIC, and cash flow all improving shows the business is growing in a cleaner and more efficient way than before. Notably, the improvement trend has been confirmed across multiple cycles, from margin to capital efficiency and cash generation. Even so, capital efficiency remains the area to verify in upcoming periods. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 127 days.
Improvement: operating efficiency is getting better, with trailing-12M net margin at 10.56% after expanding 4.2pp versus the same period last year.
Watchpoint: Capital efficiency needs cycle context.
Key risk: working capital remains tied up for too long, with cash cycle at 127.2 days.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
149.8 | 107.0 | 110.9 | 119.6 | 121.8 |
|
Cost of Goods Sold
|
97.1 | 71.1 | 78.7 | 86.6 | 0.0 |
|
Gross Profit
|
52.7 | 35.9 | 32.2 | 33.0 | 29.6 |
|
Financial Expenses
|
4.1 | 3.2 | 3.4 | 4.6 | -3.4 |
|
Selling Expenses
|
21.6 | 16.3 | 14.3 | 13.9 | -11.6 |
|
General and Administrative Expenses
|
6.5 | 7.5 | 7.3 | 7.2 | -6.0 |
|
Operating Profit
|
21.3 | 9.4 | 7.6 | 7.6 | 8.8 |
|
Profit Before Tax
|
21.1 | 9.2 | 7.8 | 7.5 | 8.8 |
|
Net Income
|
16.9 | 7.3 | 6.2 | 5.9 | 7.5 |
|
Profit Attributable to Parent
|
16.9 | 7.3 | 6.2 | 5.9 | 7.5 |
|
Earnings per Share
|
3,378.00 | 1,465.00 | 1,240.00 | 1,181.00 | 707.00 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.